Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Operating Expenses: 2013-2024

Historic Operating Expenses for vTv Therapeutics (VTVT) over the last 12 years, with Dec 2024 value amounting to $25.2 million.

  • vTv Therapeutics' Operating Expenses rose 64.45% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.8 million, marking a year-over-year increase of 19.35%. This contributed to the annual value of $25.2 million for FY2024, which is 1.20% down from last year.
  • As of FY2024, vTv Therapeutics' Operating Expenses stood at $25.2 million, which was down 1.20% from $25.5 million recorded in FY2023.
  • In the past 5 years, vTv Therapeutics' Operating Expenses registered a high of $25.7 million during FY2021, and its lowest value of $18.3 million during FY2020.
  • Its 3-year average for Operating Expenses is $25.1 million, with a median of $25.2 million in 2024.
  • Its Operating Expenses has fluctuated over the past 5 years, first dropped by 22.78% in 2020, then skyrocketed by 40.52% in 2021.
  • vTv Therapeutics' Operating Expenses (Yearly) stood at $18.3 million in 2020, then surged by 40.52% to $25.7 million in 2021, then fell by 4.32% to $24.6 million in 2022, then climbed by 3.84% to $25.5 million in 2023, then decreased by 1.20% to $25.2 million in 2024.